Advanced search×

This Week in JAMA

Author(s) unavailable

JAMA 305(2):123 (2011)

DOI: 10.1001/jama.2010.1985
Version: za2963e q8zae q8zb4 q8zc5 q8zd6 q8zed q8zfe q8zg2
Buy PDF

Similar articles you may find interesting…

  1. Topical Interleukin 1 Receptor Antagonist for Treatment of Dry Eye Disease: A Randomized Clinical Trial.
    Francisco Amparo, Mohammad H Dastjerdi, and Reza Dana

    JAMA Ophthalmology (2013) PMID 23599118

    IMPORTANCE The immunopathogenic mechanisms of dry eye disease (DED), one of the most common ophthalmic conditions, is incompletely understood. Data from this prospective, double-masked, randomized trial demonstrate that targeting interleukin 1 (IL-1) by topical application of an IL-1...
    Buy PDF
  2. Efficacy and Toxicity of Peritumoral Delivery of Nanoconjugated Cisplatin in an In Vivo Murine Model of Head and Neck Squamous Cell Carcinom...
    Stephanie M Cohen, Nick Rockefeller, and Yelizaveta Shnayder

    JAMA Otolaryngology - Head & Neck Surgery 139(4):382-387 (2013) PMID 23599074

    IMPORTANCE Treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) uses a multidisciplinary approach often limited by the toxicity and drug resistance of platinum agents. OBJECTIVES To test whether a nanocarrier-conjugated cisplatin boosting locoregional drug deli...
    Buy PDF
  3. The Mental Activity and eXercise (MAX) Trial: A Randomized Controlled Trial to Enhance Cognitive Function in Older Adults.
    Deborah E Barnes, Wendy Santos-Modesitt, and Kristine Yaffe

    JAMA Internal Medicine (2013) PMID 23545598

    IMPORTANCE The prevalence of cognitive impairment and dementia are projected to rise dramatically during the next 40 years, and strategies for maintaining cognitive function with age are critically needed. Physical or mental activity alone result in relatively small, domain-specific...
    Buy PDF